文献速递心力衰竭与心肌病

人体测量指标与射血分数降低心衰的不良结局:重新审视肥胖悖论

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
PubMed 文献 · Eur Heart J · 2023-01-01

该研究基于PARADIGM-HF试验中HFrEF患者的前瞻性数据,比较了BMI与腰高比等新型人体测量指标对心衰住院或心血管死亡的预后价值。发现BMI≥25 kg/m²相关的肥胖生存悖论在调整预后变量后消失,而腰高比显示肥胖与心衰住院风险更高独立相关。

要点

  • 在HFrEF患者中未发现肥胖生存悖论的证据。
  • 腰高比显示肥胖与心衰住院风险更高独立相关。
  • BMI与腰高比均显示肥胖增加主要结局和心衰住院风险。

核心结论

  • 在HFrEF患者中,替代人体测量指标未显示肥胖生存悖论证据。
  • 不包含体重的指标显示肥胖与心衰住院风险更高明显相关。

研究设计与样本

  • 研究为前瞻性比较ARNI与ACEI对心衰全球死亡率和发病率影响试验(PARADIGM-HF)中HFrEF患者的分析。
  • 主要结局为心衰住院或心血管死亡。
  • 人体测量指标与结局的关联全面调整了其他预后变量包括利钠肽。

主要发现

  • BMI≥25 kg/m²与较低死亡风险相关的肥胖生存悖论在调整其他预后变量后消除。
  • 腰高比(不包含体重的指标示例)的悖论较不明显,调整后全因死亡风险比(aHR)第5分位vs第1分位为1.10(95%CI 0.87-1.39)。
  • BMI和腰高比均显示肥胖与主要结局和心衰住院风险更高相关,腰高比更明显且调整后持续。
  • 腰高比第5分位vs第1分位心衰住院的aHR为1.39(95%CI 1.06-1.81)。

临床怎么用

  • 在HFrEF患者中,腰高比等不包含体重的指标可能更可靠地反映肥胖相关的心衰住院风险。
  • 评估肥胖预后时需调整利钠肽等预后变量,以避免肥胖生存悖论误导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Although body mass index (BMI) is the most commonly used anthropometric measure, newer indices such as the waist-to-height ratio, better reflect the location and amount of ectopic fat, as well as the weight of the skeleton, and may be more useful. METHODS AND RESULTS: The prognostic value of several newer anthropometric indices was compared with that of BMI in patients with heart failure (HF) and reduced ejection fraction (HFrEF) enrolled in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure. The primary outcome was HF hospitalization or cardiovascular death. The association between anthropometric indices and outcomes were comprehensively adjusted for other prognostic variables, including natriuretic peptides. An 'obesity-survival paradox' related to lower mortality risk in those with BMI ≥25 kg/m2 (compared with normal weight) was identified but this was eliminated by adjustment for other prognostic variables. This paradox was less evident for waist-to-height ratio (as an exemplar of indices not incorporating weight) and eliminated by adjustment: the adjusted hazard ratio (aHR) for all-cause mortality, for quintile 5 vs. quintile 1, was 1.10 [95% confidence interval (CI) 0.87-1.39]. However, both BMI and waist-to-height ratio showed that greater adiposity was associated with a higher risk of the primary outcome and HF hospitalization; this was more evident for waist-to-height ratio and persisted after adjustment e.g. the aHR for HF hospitalization for quintile 5 vs. quintile 1 of waist-to-height ratio was 1.39 (95% CI 1.06-1.81). CONCLUSION: In patients with HFrEF, alternative anthropometric measurements showed no evidence for an 'obesity-survival paradox'. Newer indices that do not incorporate weight showed that greater adiposity was clearly associated with a higher risk of HF hospitalization.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Butt, Petrie, Jhund, et al. Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. Eur Heart J. 2023. PMID: 36944496. doi:10.1093/eurheartj/ehad083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。